Leerink Partners Reaffirms Buy Rating for Merck & Co with $161 Target

Leerink Partners analyst Daina Graybosch has reaffirmed her 'Buy' rating for Merck & Co (MRK.US), maintaining a target price of $161. According to TipRanks data, Graybosch's success rate over the past year is 38.9%, with a total average return of -7.5%. This means that in 38.9% of her ratings, the virtual portfolio earned a positive return from the stock.

TipRanks provides analysis data from financial analysts and calculates their performance based on their recommendations. Graybosch's rating is part of this broader dataset, which includes information about her past performance as an analyst.